Sechenov School
Home › Pharmacology › Antipseudomonal Penicillins

Antipseudomonal Penicillins

For medical students2 min readUpdated 2026-10-10

Antipseudomonal penicillins are a group of broad-spectrum antibiotics valued primarily for their high activity against Pseudomonas aeruginosa. This category traditionally includes two classes: carboxypenicillins and ureidopenicillins.

Primary TargetPseudomonas aeruginosa
Dosage RegimenHigh doses required due to poor diffusion through porin channels
VulnerabilityHydrolyzed by most bacterial β-lactamases
Specific RiskCarbenicillin may cause bleeding diathesis and hypokalemia

Carboxypenicillins: Structural Features and Spectrum

These are broad-spectrum antibiotics that are less potent than aminopenicillins against most organisms. Their key chemical feature is the presence of a carboxyl group in the side chain.

This structure gives the molecules a negative charge, providing stability against certain chromosomal bacterial β-lactamases. However, due to the lack of an amino group, the antibiotic molecules diffuse poorly through the porin channels of Gram-negative bacteria. Consequently, high doses are required to achieve effective intracellular concentrations.

Spectrum of Activity:

Characteristics of Carboxypenicillins

The primary indication for these drugs is infections caused by Pseudomonas aeruginosa.

  1. Carbenicillin

A derivative of 6-aminopenicillanic acid. It is acid-labile, poorly absorbed in the gastrointestinal tract, and therefore administered exclusively parenterally (intramuscularly or intravenously) 4–6 times daily. It does not cross the blood-brain barrier (BBB), is approximately 50% plasma protein-bound, and is eliminated predominantly by the kidneys. It is inactivated by β-lactamases.

In addition to typical penicillin hypersensitivity reactions (anaphylactic shock, urticaria, angioedema), carbenicillin has specific toxic effects:

  1. Carfecillin

A phenyl ester of carbenicillin. Its main advantage is acid stability and good gastrointestinal absorption, allowing for oral administration 3 times daily.

  1. Ticarcillin

More potent than carbenicillin, especially against Pseudomonas aeruginosa. Like carbenicillin, it is poorly absorbed orally and must be administered parenterally 4–6 times daily.

Ureidopenicillins

This group includes azlocillin, piperacillin, and mezlocillin.

Their spectrum of activity is largely similar to carboxypenicillins, but they offer several important advantages:

Like carboxypenicillins, they are degraded by staphylococcal and Gram-negative β-lactamases and must be administered parenterally.

Clinical Applications and Comparative Potency

Both groups share a primary clinical utility: the ability to eradicate Pseudomonas aeruginosa. Target pathogens also include Proteus and E. coli.

Main Indications:

Ranking of Antipseudomonal Activity (in descending order):

  1. Azlocillin and Piperacillin (highest activity)
  2. Mezlocillin and Ticarcillin (moderate activity)
  3. Carbenicillin (lowest activity in the group)

Mnemonic

To remember the ranking of antipseudomonal activity (from strongest to weakest): Active Patients May Travel Comfortably (Azlocillin = Piperacillin > Mezlocillin = Ticarcillin > Carbenicillin).

Frequently asked questions

What are the pharmacokinetic parameters of carbenicillin?

Carbenicillin pharmacokinetics are characterized by poor gastrointestinal absorption and primary renal elimination.

  • Absorption: Acid-labile and degraded in the stomach; administered parenterally (IM or IV).
  • Distribution: Does not cross the blood-brain barrier; plasma protein binding is approximately 50%.
  • Elimination: Excreted primarily by the kidneys.
  • Dosage Regimen: Administered 4–6 times daily.
Which beta-lactamase inhibitors are combined with antipseudomonal penicillins?

Antipseudomonal penicillins are combined with $\beta$-lactamase inhibitors such as clavulanate and tazobactam.

Fixed combinations include:

  • Piperacillin + tazobactam (features the broadest antimicrobial spectrum in this class).
  • Ticarcillin + clavulanate.

While inhibitors possess weak intrinsic antibacterial activity themselves, they bind to bacterial β-lactamases and irreversibly inactivate them, protecting the companion antibiotic from hydrolysis.

What is the cellular mechanism of antibacterial action of antipseudomonal penicillins?

Antipseudomonal penicillins act by disrupting bacterial cell wall synthesis, exerting a bactericidal effect.

The process involves:

  • Enzyme inhibition: The antibiotic binds to penicillin-binding proteins (PBPs), inhibiting transpeptidase enzymes.
  • Synthesis disruption: Formation of cross-linked peptidoglycan on the outer surface of the cytoplasmic membrane is blocked.
  • Autolysin activation: Accumulation of uncross-linked peptidoglycan precursors triggers endogenous autolytic systems.
  • Lysis: Loss of cell wall structural integrity leads to bacterial cell lysis and death.
Why are carboxypenicillins prescribed in very high doses?

Due to the lack of an amino group in their chemical structure, they penetrate bacterial porin channels poorly. To achieve the required intracellular concentration, the dosage must be significantly increased.

Can these antibiotics be taken orally?

Most agents in this group (carbenicillin, ticarcillin, and all ureidopenicillins) are degraded in the stomach or absorbed poorly, so they are given parenterally. The exception is carfecillin, which is acid-stable and suitable for oral administration.

How does carbenicillin affect blood electrolyte levels?

It is formulated as a disodium salt, which can lead to hypernatremia (risky in heart failure). Additionally, it is excreted by the kidneys as a non-reabsorbable anion, dragging potassium along with it in the distal tubules and causing hypokalemia.

Go deeper

More topics in Pharmacology

MetoprololCytochrome P450 SystemClonidine: Mechanism, Effects and UsesBiologic Agents in Rheumatoid ArthritisGanglionic BlockersPulmonary Surfactants: Pharmacology and Clinical UseBone Marrow Preparations: Myelopid PharmacologyHerbal AntisepticsNaphazoline: Pharmacology, Mechanism and Clinical UseParacetamolAnticoagulantsAtenololPharmacology →